JW Therapeutics

About:

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

Website: http://www.jwtherapeutics.com/

Top Investors: Temasek Holdings, ARCH Venture Partners, WuXi AppTec, Mirae Asset, HongShan

Description:

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.

Total Funding Amount:

$190M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2016-02-01

Hub Tags:

Exited Unicorn

Founders:

James Li

Number of Employees:

251-500

Last Funding Date:

2020-06-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai